SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-24-004228
Filing Date
2024-01-12
Accepted
2024-01-12 16:00:15
Documents
1
Period of Report
2023-12-18

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 6630
  Complete submission text file 0000950170-24-004228.txt   8140
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 41 HARRIS CT DANVILLE CA 94526
Business Address
Flynn James P (Reporting) CIK: 0001955965 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41827 | Film No.: 24532020